Major Thoroughbred Sales Companies Ban Off-Label Bisphosphonate Use
- Topics: Horse Care, Lameness, Medications, Welfare and Industry
No account yet? Register
Officials from the Keeneland Association, Fasig-Tipton Company Inc., and Ocala Breeders’ Sales Company Inc. (OBS)—the three major U.S. Thoroughbred auction companies—jointly announced March 25 that they will enable buyers of horses younger than 4 years old to have those horses tested for bisphosphonates.
The policy is undertaken to ban off-label use of these drugs. The revised Conditions of Sale for each of these sales companies will take effect July 1.
At each of the three sales companies, buyers of young horses can request testing for bisphosphonates to be performed at the time of purchase. If the sale horse tests positive, a buyer has the right, within 24 hours of notification, to rescind the sale
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with